BABYLAT
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment of human milk.
BABYLAT
Social Links:
Industry:
Medical Medical Device
Founded:
2021-01-01
Address:
Bern, Bern, Switzerland
Country:
Switzerland
Website Url:
http://www.babylat.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
30 K CHF
Technology used in webpage:
Google Apps For Business
Similar Organizations
Hallsey
Hanerxi is a pen injector developer of an adjustable precision injection pen for drug delivery in chronic ailments and diseases.
Sensome
Sensome offers micro-sensor technology to turn medical devices into connected healthcare devices.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Employees Featured
Founder
Investors List
MassChallenge Switzerland
MassChallenge Switzerland investment in Non Equity Assistance - Babylat
Ypsomed Innovation Fund
Ypsomed Innovation Fund investment in Grant - Babylat
Official Site Inspections
http://www.babylat.com
- Host name: 185.215.4.75
- IP address: 185.215.4.75
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "Babylat"
Babylat - Crunchbase Company Profile & Funding
Organization. Babylat . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Babylat is an enricher device is the first …See details»
Babylat - Products, Competitors, Financials, Employees, …
Babylat's device allows for the preparation of human milk-origin fortifiers onsite, providing a unique solution for personalized nutrition that adheres to the World Health Organization's …See details»
Blank page
Babylat is the first automated tabletop device for human milk protein and fat enrichment. It is easy to use even without special medical training because all enrichment processes are automated …See details»
Babylat Company Profile 2024: Valuation, Funding & Investors
Zina Yudina Ph.D is the founder of Babylat. Who is the CEO of Babylat? Zina Yudina Ph.D is the CEO of Babylat. Where is Babylat headquartered? Babylat is headquartered in Bern, …See details»
Babylat - Overview, News & Similar companies | ZoomInfo.com
Babylat is a company that operates in the Hospital & Health Care industry. It employs 11-20 people and has $1M-$5M of revenue. The company is headquartered in Bern, Berne, …See details»
Babylat - Contacts, Employees, Board Members, Advisors & Alumni
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment of human milk. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Babylat - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment of human milk. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Babylat GmbH - Venture Kick
Feb 8, 2022 Babylat GmbH: Premature infants with very low birth weight (<1.5kg) need four times higher protein contents than human milk alone can provide (most optimal food for any …See details»
Babylat - Company Profile - Tracxn
Sep 18, 2024 Babylat - Developer of a device for milk enrichment. Raised funding from 2 investors. Founded by Zina Yudina in the year 2020.See details»
Babylat | Company | Mindmaps
A novel automated device - BABYLAT Enricher - concentrates the protein fraction from human milk on-site in hospitals. This innovative proprietary device allows fast and efficient protein …See details»
Babylat - BioAlps
Avenue de Sécheron 15 1202 Geneva, Switzerland T +41 22 545 12 91. c/o BIOPÔLE SA Secteur Esplanade / Bâtiment Serine Route de la Corniche 8 1066 Epalinges, SwitzerlandSee details»
Zina Yudina - CEO BABYLAT - BABYLAT | LinkedIn - LinkedIn Schweiz
BABYLAT · We plan to improve quality of live of most vulnerable patients-premature babies- by making their diet to be 100% human milk-based especially at the start of their already very …See details»
Babylat GmbH - startup.ch
Babylat GmbH: Premature infants with very low birth weight (<1.5kg) need four times higher protein contents than human milk alone can provide (most optimal food for any neonate). …See details»
Babylat - Funding, Financials, Valuation & Investors - Crunchbase
Babylat is an enricher device is the first automated, small-scale tabletop device for the protein enrichment of human milk. Search Crunchbase. ... How much funding has this organization …See details»
Nurturing Innovations: Spotlight on Breastfeeding & Neonatal Care
Aug 22, 2024 Zina: Babylat is now Babylat AG, thanks to the generous support from investors we recently gained. This support allows us to proceed with device prototyping, and we have …See details»
BABYLAT - LinkedIn
BABYLAT Hospitals and Health Care Bern, Berne 227 followers Solution to save the most fragile livesSee details»
Babylat - EU-Startups
BABYLAT Enricher device is an automated, small-scale tabletop device for the protein enrichment of human milk. The proteins are extracted from human milk and after extraction, this …See details»
Supplementary nutrition for premature babies based on human milk
Oct 15, 2021 How do you envisage the future of Babylat? “I would love to see this device used in every hospital with neonatal intensive care units to lower the mortality rate among premature …See details»
CHF 10,000 for a device enhancing preterm infant nutrition, AI …
Mar 30, 2021 Babylat: enhancing preterm infant nutrition Premature infants with very low birth weight (<1.5kg) need four times higher protein contents than human milk alone can provide …See details»
New device improves nutrition for premature babies
The Babylat Enricher is designed as a compact, fully automated device that can provide the protein-rich fortifier from human milk directly at the point of care – in the hospital or at donor …See details»